Retroperitoneal lymphadenectomy and resection for testicular cancer: An update on best practice

Therapeutic Advances in Urology

Volumn 4, Issue 4, 2012, Pages 187-205

  Heidenreich, Axel ^a   Pfister, David ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

germ cell tumour; postchemotherapy RPLND; retroperitoneal lymph node dissection; retroperitoneal lymphadenectomy; testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ACUTE KIDNEY FAILURE; ADVANCED CANCER; ATELECTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHYLOUS ASCITES; CLINICAL PROTOCOL; DISEASE SPECIFIC SURVIVAL; GOOD CLINICAL PRACTICE; HUMAN; HYPERAMYLASEMIA; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; LYMPHADENECTOMY; NON SEMINOMATOUS GERMINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORCHIECTOMY; PARALYTIC ILEUS; PATIENT SAFETY; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; RETROPERITONEAL LYMPHADENECTOMY; REVIEW; RISK ASSESSMENT; SALVAGE THERAPY; TESTIS CANCER; TESTIS NONSEMINOMA CANCER; TUMOR VOLUME; WOUND INFECTION;

EID: 84863963470     PISSN: 17562872     EISSN: 17562880     Source Type: Journal    
DOI: 10.1177/1756287212443170     Document Type: Article

References (90)

1. Albers P. Albrecht W. Algaba F. Bokemeyer C. Cohn-Cedermark G. Horwich A. (2005) Guidelines on testicular cancer. Eur Urol 48: 885–894.
2. Albers P. Ganz A. Hannig E. Miersch W.D. Müller S.C. (2000) Salvage surgery of chemorefractory germ cell tumors with elevated markers. J Urol 164: 381–384.
3. Albers P. Höltl W. Heidenreich A. Aharinejad S. (2004a) Thoracoabdominal resection of retrocrural residual tumors. Akt Urol 35: 141–150.
4. Albers P. Melchior D. Müller S.C. (2003a) Extensive surgery in testis cancer. Eur Urol 44: 233–244.
5. Albers P. Siener R. Kliesch S. Weissbach L. Krege S. Sparwasser C. for the German Testicular Cancer Study Group (2003a) Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 21: 1505–1512.
6. Albers P. Weissbach L. Krege S. Kliesch S. Hartmann M. Heidenreich A. for the German Testicular Cancer Study Group (2004b) Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group. J Urol 171: 1835–1838.
7. Aprikian A.G. Herr H.W. Bajorin D.F. Bosl G.J. (1994) Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer 74: 1329–1334.
8. Baniel J. Foster RS. Einhorn L.H. Donohue J.P. (1995) Late relapse of clinical stage I testicular cancer. J Urol 154: 1370.
9. Barentsz J. Takahashi S. Oyen W. Mus R. De Mulder P. Reznek R. (2006) Commonly used imaging techniques for diagnosis and staging. J Clin Oncol 24: 3234–3244.
10. Becherer A. De Santis M. Karanikas G. Szabo M. Bokemeyer C. Dohmen B.M. (2005) FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. Eur J Radiol 54: 284–288.
11. Beck S.D. Foster R.S. Bihrle R. Donohue J.P. Einhorn L.H. (2007) Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer 110: 1235–1240.
12. Beck S.D. Foster R.S. Bihrle R. Einhorn L.H. Donohue J.P. (2005) Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 23: 6149–6156.
13. Beck S.D. Foster R.S. Bihrle R. Koch M.O. Wahle G.R. Donohue J.P. (2001) Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection. J Urol 165: 1517–1520.
14. Beck S.D. Lalka S.G. (1998) Long-term results after inferior vena cava resection during retroperitoneal lymphadenectomy for metastatic germ cell cancer. J Vasc Surg 28: 808–814.
15. Beck S.D.W. Foster R.S. (2006) Long-term outcome of retroperitoneal lymph node dissection in the management of testis cancer. World J Urol 24: 267–272.
16. Bhardwa J.M. Powles T. Berney D. Baithun S. Nargund V.H. Oliver R.T. (2005) Assessing the size and stage of testicular germ cell tumours: 1984–2003. BJU Int 96: 819–821.
17. Cespedes R.D. Peretsman S.J. (1999) Retroperitoneal recurrences after retroperitoneal lymph node dissection for low-stage nonseminomatous germ cell tumors. Urology 54: 548–552.
18. Christmas T.J. Smith G.L. Kooner R. (1998) Vascular interventions during post-chemotherapy retroperitoneal lymph node dissection for metastatic testis cancer. Eur J Surg Oncol 292–297.
19. Debono D.J. Heilman D.K. Einhorn L.H. Donohue J.P. (1997) Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumours. J Clin Oncol 15: 1455–1464.
20. De Santis M. Becherer A. Bokemeyer C. (2004) 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update from the multicenter SEMPET trial. J Clin Oncol 22: 1034–1039.
21. de Wit M. Brenner W. Hartmann M. Kotzerke J. Hellwig D. Lehmann J. (2008) [18F]-FDG-PET in clinical stage I/II non-seminomatous germ cell tumours: results of the German multicentre trial. Ann Oncol 19: 1619–1623.
22. Donohue J.P. Foster R.S. Rowland R.G. Bihrle R. Jones J. Geier G. (1990) Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 144: 287.
23. Donohue J.P. Thornhill J.A. Foster R.S. Rowland R.G. Bihrle R. (1993a) Primary retroperitoneal lymph node dissection in clinical stage A nonseminomatous germ cell testis cancer. Review of the Indiana University experience 1965–1989. Br J Urol 71: 326.
24. Donohue J.P. Thornhill J.A. Foster R.S. Rowland R.G. Bihrle R. (1993b) Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965–1989): modifications of technique and impact on ejaculation. J Urol 149: 237–243.
25. Eggener S.E. Carver B.S. Loeb S. Kondagunta G.V. Bosl G.J. Sheinfeld J. (2007) Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimes for metastatic testicular germ cell tumors. Cancer 109: 528–535.
26. Ehrlich Y. Brames M.J. Beck S.D. Foster R.S. Einhorn L.H. (2010) Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission? J Clin Oncol 28: 531–536.
27. Ehrlich Y. Yossepovitch O. Kedar D. Baniel J. (2006) Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection. BJU Int 97: 1221–1224.
28. Fizazi K. Oldenburg J. Dunant A. Chen I. Salvioni R. Hartmann J.T. (2008) Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol 19: 259–264.
29. Fizazi K. Tjulandin S. Salvioni R. Germà-Lluch J.R. Bouzy J. Ragan D. (2001) Viable malignant cells after primary chemotherapy for disseminated nonseminatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy results from an international study. J Clin Oncol 19: 2647–2657.
30. Flechon A. Bompas E. Biron P. Droz J.P. (1979) Management of post-chemotherapy residual masses in advanced seminoma. J Urol 168: 1975–1979.
31. Fossä S.D. Borge L. Aass N. Johannessen N.B. Stenwig A.E. Kaalhus O. (1987) The treatment of advanced metastatic seminoma: experience in 55 cases. J Clin Oncol 5: 1071–1077.
32. Fossa S.D. Ous S. Lien H.H. Stenwig A.E. (1989) Post-chemotherapy lymph node histology in radiologically normal patients with metastatic nonseminomatous testicular cancer. J Urol 141: 557–559.
33. Friedman E.L. Garnick M.B. Stomper P.C. Mauch P.M. Harrington D.P. Richie J.P. (1985) Therapeutic guidelines and results in advanced seminoma. J Clin Oncol 3: 1325–1332.
34. Fujioka T. Nomura K. Okamoto T. Aoki H. Ohhori T. Kubo T. (1993) Retroperitoneal lymph node dissection for testicular tumors using the thoracoabdominal approach. Int Surg 78: 154–158.
35. Gerl A. Clemm C. Schmeller N. Hentrich M. Lamerz R. Williams W. (1997) Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 8: 41–47.
36. Hartmann J.T. Candelaria M. Kuczyk M.A. Schmoll H.J. Bokemeyer C. (1997) Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. Eur J Cancer 33: 843–847.
37. Heidenreich A. (2007) Residual tumor resection following inductive chemotherapy in advanced testicular cancer. Eur Urol 51: 299–301.
38. Heidenreich A. Albers P. Hartmann M. Kliesch S. Kohrmann K.U. Krege S. for the German Testicular Cancer Study Group (2003) Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 169: 1710–1714.
39. Heidenreich A. Derakhshani P. Krug B. Engelmann U.H. (1998a) Evaluation of the inferior vena cava by magnetic resonance imaging in advanced testicular germ cell tumors. Eur Urol 49: 196.
40. Heidenreich A. Dieckmann K.P. Schmelz H. Winter C. Pfister D. (2011) Prognostic clinical parameters to predict the necessity of reconstructive vascular surgery for patients who undergo postchemotherapy retroperitoneal lymph node dissection for advanced nonseminomatous germ cell tumours. Results of the German Testicular Cancer Study Group and the Association of Urologic Oncology. J Urol, AUA abstract # 832.
41. Heidenreich A. Moul J.W. McLeod D.G. Mostofi F.K. Engelmann U.H. (1997) The role of retroperitoneal lymphadenectomy in mature teratoma of the testis. J Urol 157: 160–163.
42. Heidenreich A. Ohlmann C. Hegele A. Beyer J. (2005) Repeat retroperitoneal lymphadenectomy in advanced testicular cancer. Eur Urol 47: 64–71.
43. Heidenreich A. Pfister D. Witthuhn R. Thüer D. Albers P. (2009) Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. Eur Urol 55: 217–224.
44. Heidenreich A. Seger M. Schrader A.J. Hofmann R. Engelmann U.H. (2004) Surgical considerations in residual tumor resection following inductive chemotherapy for advanced testicular cancer. Eur Urol 162(Suppl. 3): 632.
45. Heidenreich A. Sesterhenn I.A. Mostofi F.K. Moul J.W. (1998b) Prognostic factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 83: 1002–1011.
46. Hendry W.F. Norman A.R. Dearnaley D.P. Fisher C. Nicholls J. Huddart R.A. (2002) Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 94: 1668–1676.
47. Herr H.W. (1997) Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer? Br J Urol 80: 653–657.
48. Herr H.W. Sheinfeld J. Puc H.S. Heelan R. Bajorin D.F. Mencel P. (1997) Surgery for a post-chemotherapy residual mass in seminoma. J Urol 157: 860–862.
49. Hofmockel G. Gruss A. Theiss M. (1996) Chemotherapy in advanced seminoma and the role of postcytostatic retroperitoneal lymph node dissection. Urol Int 57: 38–42.
50. Hogeboom W.R. Hoekstra H.J. Mooyart E.L. Sleijfer D.T. Schraffordt Koops H. (1993) Magnetic resonance imaging of retroperitoneal lymph node metastases of non-seminomatous germ cell tumors of the testis. Eur J Surg Oncol 19: 429–437.
51. Huddart R.A. O–Doherty M.J. Padhani A. Rustin G.J. Mead G.M. Joffe J.K. For the NCRI Testis Tumour Clinical Study Group (2007) 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22–the NCRI Testis Tumour Clinical Study Group. J Clin Oncol 25: 3090–3095.
52. Jewett M.A. Kong Y.S. Goldberg S.D. Sturgeon J.F. Thomas G.M. Alison R.E. (1988) Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation. J Urol 139: 1220.
53. Kamat M.R. Kulkarni J.N. Tongoankar H.B. Ravi R. (1992) Value of retroperitoneal lymph node dissection in advanced testicular seminoma. J Surg Oncol 51: 65–67.
54. Kollmannsberger C. Daneshmand S. So A. Chi K.N. Murray N. Moore C. (2010) Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery. J Clin Oncol 28: 537–542.
55. Krege S. Beyer J. Souchon R. Albers P. Albrecht W. Algaba F. (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 53: 478–496.
56. Krug B. Heidenreich A. Dietlein M. Lackner K. (1999) Lymphknotenstaging maligner testikulärer Keimzelltumoren. Fortschr Röntgenstr 171: 87–94.
57. Leibovitch I. Foster R.S. Kopecky K.K. Donohue J.P. (1995a) Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell tumor using size criteria of retroperitoneal lymph nodes. J Urol 154: 1759–1763.
58. Leibovitch I. Foster R.S. Kopecky K.K. Albers P. Ulbright T.M. Donohue J.P. (1998) Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitative immunohistochemical, histopathologic, and radiologic assessment. J Clin Oncol 16: 261–268.
59. Leibovitch I. Foster R.S. Ulbright T.M. Donohue J.P. (1995b) Adult primary pure teratoma of the testis. The Indiana experience. Cancer 75: 2244–2250.
60. Leibovitch I. Mor Y. Golomb J. Ramon J. (2002) The diagnosis and management of postoperative chylous ascites. J Urol 167: 449–457.
61. McKiernan J.M. Motzer R.J. Bajorin D.F. Bacik J. Bosl G.J. Sheinfeld J. (2003) Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence and outcome. Urology 62: 732–736.
62. Meyer C.A. Conces D.J. (2002) Imaging of intrathoracic metastases of nonseminomatous germ cell tumors. Chest Surg Clin N Am 12: 717–738.
63. Mosharafa A.A. Foster R.S. Koch M.O. Bihrle R. Donohue J.P. (2004) Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 171: 1839–1841.
64. Mosharafa A.A. Foster R.S. Leibovich C.C. Bihrle R. Johnson C. Donohue J.P. (2003) Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 169: 2126–2128.
65. Nash P.A. Leibovitch I. Foster R.S. Bihrle R. Rowland R.G. Donohue J.P. (1998) En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes. J Urol 159: 707–710.
66. Nicolai N. Miceli R. Necchi A. Biasoni D. Catanzaro M. Milani A. (2010) Retroperitoneal lymph node dissection with no adjuvant chemotherapy in clinical stage I nonseminomatous germ cell tumours: long-term outcome and analysis of risk factors of recurrence. Eur Urol [ePub ahead of print].
67. Oldenburg J. Alfsen G.C. Lien H.H. Aas N. Waehre H. Fossa S.D. (2003) Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 21: 3310–3317.
68. Perrotti M. Ankem M. Bancilla A. deCarvalho V. Amenta P. Weiss R. (2004) Prospective metastatic risk assignment in clinical stage I nonseminomatous germ cell testis cancer: a single institution pilot study. Urol Oncol 22: 174–177.
69. Pfister D. Busch J. Winter C. Albers P. Schrader M. Dieckmann K.P. (2011) Pathohistological findings in patients with nonseminomatous germ cell tumours who undergo postchemotherapy retroperitoneal lymph node dissection for small tumours. J Urol, AUA abstract # 830.
70. Pont J. Höltl W. Kosak D. Machacek E. Kienzer H. Julcher H. (1990) Risk-adapted treatment choice in stage I nonseminomatous testicular germ cell cancer by regarding vascular invasion in the primary tumor: a prospective trial. J Clin Oncol 8: 16–19.
71. Puc H.S. Heelan R. Mazumdar M. Herr H. Sheinfeld J.E. Vlasmis V. (1996) Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan Kettering Cancer Center. J Clin Oncol 14: 454–460.
72. Qvist H.L. Fossa S.D. Ous S. Hoie J. Stenwig A.E. Giercksky K.E. (1991) Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses? J Urol 145: 300–302.
73. Rabbani F. Goldenberg S.L. Gleave M.E. Paterson R.F. Murray N. Sullivan L.D. (1998) Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of the residual mass sufficient? Br J Urol 81: 295–300.
74. Rassweiler J.J. Scheitlin W. Heidenreich A. Laguna M.P. Janetschek G. (2008) Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Eur Urol 54: 1004–1015.
75. Ravi R. Rao R.R. Shanta V. (1994) Integrated approach to the management of patients with advanced germ cell tumors of the testis. J Surg Oncol 55: 47–51.
76. Read G. Stenning S.P. Cullen M.H. Parkinson M.C. Horwich A. Kaye S.B. (1992) Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 10: 1762–1768.
77. Schultz S.M. Einhorn L.H. Conces D.J. Williams S.D. Loehrer P.J. (1989) Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 7: 1497–1503.
78. Sexton W.J. Wood C.G. Kim R. Pisters L.L. (2003) Repeat retroperitoneal lymph node dissection for metastatic testis cancer. J Urol 169: 1353–1356.
79. Skinner D.G. Melamud A. Lieskovsky G. (1982) Complications of thoracoabdominal retroperitoneal lymph node dissection. J Urol 127: 1107–1110.
80. Sonneveld D.J. Sleijfer D.T. Koops H.S. Keemers-Gels M.E. Molenaar W.M. Hoekstra H.J. (1998) Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer 82: 1343–1351.
81. Stephenson A.J. Bosl G.J. Motzer R.J. Kattan M.W. Stasi J. Bajorin D.F. (2005) Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. J Clin Oncol 23: 2781–2788.
82. Stephenson A.J. Tal R. Sheinfeld J. (2006) Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer. J Urol 176: 1996–1999.
83. Toner G.C. Panicek D.M. Heelan R.T. Geller S.L. Lin S.Y. Bajorin D. (1990) Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 8: 1683–1694.
84. Vergouwe Y. Steyerberg E.W. de Wit R. Roberts J.T. Keizer H.J. Collette L. (2003) External validation of a prediction rule for residual mass histology in testicular cancer: an evaluation for good prognosis patients. Br J Cancer 88: 843–847.
85. Vergouwe Y. Steyerberg E.W. Foster R.S. Habbema J.D.F. Donohue J.P. (2001) Validation of a prediction model and its predictors for the histology of residual masses in nonseminonatous testicular cancer. J Urol 165: 84–88.
86. Vergouwe Y. Steyerberg E.W. Foster R.S. Sleijfer D.T. Fossa S.D. Gerl A. (2007) Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicenter validation with more than 1000 patients. Eur Urol 51: 424–432.
87. Waples M.J. Messing E.M. (1993) Redo retroperitoneal lymphadenectomy for germ cell tumor. Urology 42: 1–4.
88. White P.M. Adamson D.J.A. Howard G.C.W. Wright A.R. (1999) Imaging of the thorax in the management of germ cell testicular tumours. Clin Radiol 54: 207–211.
89. Wood D.P. Herr H.W. Heller G. Vlamis V. Sogani P.C. Motzer R.J. (1992) Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors. J Urol 148: 1812–1816.
90. Yoon G.H. Stein J.P. Skinner D.G. (2005) Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update. Urol Oncol 23: 168.